Catalyst Wire Dossier Catalyst Wire Dossier

IL13-PE38QQR cytotoxin

IL13-PE38QQR (interleukin-13 fused to Pseudomonas exotoxin PE38QQR)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL13-PE38QQR cytotoxin, covering 2014-11-14 to 2014-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [Phase 1, Phase 2]

See pricing